Mavacamten and the Reframing of Obstructive Hypertrophic Cardiomyopathy as a Medically Treatable Disease. JHCS [Internet]. 2022 Oct. 5 [cited 2026 Oct. 30];3(1):16-21. Available from: https://pragmajournals.org/index.php/JHCS/article/view/168